门冬氨酸钾镁治疗溶栓后室性心律失常疗效研究  

Effects of Potassium Magnesium Aspartate on Ventricular Arrhythmia after Thrombolysis

作　　者：黄纪文[1] 冯艳翠[1] 黄笑娟[1] 

机构地区：[1]广东省开平市中心医院,529300

出　　处：《临床合理用药杂志》2011年第02X期12-13,共2页Chinese Journal of Clinical Rational Drug Use

摘　　要：目的观察急性心肌梗死(AMI)患者早期采用静脉滴注门冬氨酸钾镁治疗对溶栓后室性心律失常疗效的影响。方法选取66例AMI患者分为治疗组和对照组,两组均给予溶栓治疗,治疗组在常规治疗的基础上加用门冬氨酸钾镁治疗,观察其对室性心律失常的影响。结果治疗组恶性室性心律失常发生率明显少于对照组,差别有统计学意义(P<0.05)。结论门冬氨酸钾镁能明显减少AMI恶性室性心律失常的发生,减少并发症。Objective To observe the effect of potassium magnesium aspartate on ventricular arrhythmia in patients with Acute myocardial infarction After thrombolysis.Methods 66 acute myocardial infarction patients treated in our hospital from January,2007 to March,2010.The AMI patients were radomized into two groups：treated group（n=36） and control group（n=30）.Both groups were given thrombolytic therapy and conventional therapy,the treatment group was treated based on the use of potassium magnesium aspartate treatment.Ventricular arrhythmia observed before discharge.Results Malignant ventricular arrhythmia on treatment group was less than the control group,there was statistically significant difference（P0.05）.Conclusion Potassium magnesium aspartate can reduce the Acute myocardial infarction in patients with malignant ventricular arrhythmia.

关 键 词：急性心肌梗死 门冬氨酸钾镁 恶性室性心律失常 

分 类 号：R542.22[医药卫生—心血管疾病]